PMGC HOLDINGS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
PMGC HOLDINGS INC. (ELAB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 66 shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-03-28
- PMGC HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was -92.43K shares.
- PMGC HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 0.00 shares.
- PMGC HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-12-12 was 105.00K shares.
- PMGC HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-09-30 was 226.00K shares.
- PMGC HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 66.00 shares, a 60.48% decline from fiscal 2023.
- PMGC HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 167.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 2 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 2 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 5 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -92.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -92.43K shares derived: sum of 2 quarters · filed 2025-03-28 | 66.00 shares 10-K · filed 2025-03-28 | ||||||||
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 92.50K shares 10-Q · filed 2024-11-14 | |||||||||
| 2024-06-30 | 92.50K shares 10-Q · filed 2024-08-14 | ||||||||||
| 2024-03-06 | 80.00K shares 10-Q · filed 2024-08-14 | ||||||||||
| 2024-01-31 | 12.50K shares 10-Q · filed 2024-08-14 | ||||||||||
| 2024-01-01 | 12.50K shares 10-Q · filed 2024-05-15 | ||||||||||
| 2023-12-31 | 167.00 shares 10-K · filed 2025-03-28 | 234.00K shares 10-Q · filed 2024-08-14 | |||||||||
| 2023-07-01 | 1.50K shares 10-K · filed 2024-03-29 | ||||||||||
| 2023-06-30 | 80.00K shares 10-Q · filed 2024-08-14 | 222.50K shares 10-Q · filed 2023-12-11 | |||||||||
| 2023-02-01 | 10.00K shares 10-Q · filed 2024-08-14 | ||||||||||
| 2022-12-12 | 105.00K shares 10-K · filed 2024-03-29 | ||||||||||
| 2022-11-01 | 262.00K shares 10-K · filed 2024-03-29 | ||||||||||
| 2022-09-30 | 226.00K shares 10-Q · filed 2023-12-11 | ||||||||||
| 2022-06-01 | 16.00K shares 10-Q · filed 2023-12-11 | ||||||||||
| 2022-04-25 | 45.00K shares 10-Q · filed 2023-12-11 | 45.00K shares 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |